AIONX
Price
$16.60
Change
-$0.05 (-0.30%)
Updated
May 8 closing price
Net Assets
182.82M
RERBX
Price
$54.37
Change
+$0.07 (+0.13%)
Updated
May 8 closing price
Net Assets
128.01B
Ad is loading...

AIONX vs RERBX

Header iconAIONX vs RERBX Comparison
Open Charts AIONX vs RERBXBanner chart's image
AQR International Momentum Style N
Price$16.60
Change-$0.05 (-0.30%)
VolumeN/A
Net Assets182.82M
American Funds Europacific Growth R2
Price$54.37
Change+$0.07 (+0.13%)
VolumeN/A
Net Assets128.01B
AIONX vs RERBX Comparison Chart
Loading...
View a ticker or compare two or three
VS
AIONX vs. RERBX commentary
May 09, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AIONX is a Buy and RERBX is a Buy.

Ad is loading...
FUNDAMENTALS
Fundamentals
RERBX has more cash in the bank: 128B vs. AIONX (183M). AIONX pays higher dividends than RERBX: AIONX (2.72) vs RERBX (0.47). AIONX was incepted earlier than RERBX: AIONX (12 years) vs RERBX (23 years). RERBX (1.56) is less costly to investors than AIONX (0.98). AIONX is a more actively managed with annual turnover of: 56.00 vs. RERBX (30.00). RERBX has a lower initial minimum investment than AIONX: RERBX (250) vs AIONX (2500). RERBX annual gain was more profitable for investors over the last year : -1.68 vs. AIONX (-2.62). AIONX return over 5 years is better than : 35.49 vs. RERBX (21.37).
AIONXRERBXAIONX / RERBX
Total Expense Ratio0.881.5656%
Annual Report Gross Expense Ratio0.981.5663%
Fund Existence12 years23 years-
Gain YTD15.2786.922221%
Front LoadN/AN/A-
Min. Initial Investment25002501,000%
Min. Initial Investment IRAN/AN/A-
Net Assets183M128B0%
Annual Yield % from dividends2.720.47577%
Returns for 1 year-2.62-1.68156%
Returns for 3 years16.7618.1892%
Returns for 5 years35.4921.37166%
Returns for 10 years39.6211.65340%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
RARE35.982.56
+7.66%
Ultragenyx Pharmaceutical
WLKP23.200.14
+0.61%
Westlake Chemical Partners LP
L87.970.14
+0.16%
Loews Corp
LFCR6.89-0.11
-1.57%
Lifecore Biomedical
WLDS1.50-0.08
-5.06%
Wearable Devices Ltd